{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:22:18Z","timestamp":1791908538245,"version":"4.3.4"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-025-09023-8","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T19:09:32Z","timestamp":1739300972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Lipid Metabolism: An Emerging Player in Sj\u00f6gren\u2019s Syndrome"],"prefix":"10.1007","volume":"68","author":[{"given":"Keni","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lufei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincheng","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4629-7631","authenticated-orcid":false,"given":"Jianping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6588-2951","authenticated-orcid":false,"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"9023_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.clim.2017.04.005","volume":"182","author":"FB Vivino","year":"2017","unstructured":"Vivino FB (2017) Sjogren\u2019s syndrome: clinical aspects. Clin Immunol 182:48\u201354. https:\/\/doi.org\/10.1016\/j.clim.2017.04.005","journal-title":"Clin Immunol"},{"issue":"11","key":"9023_CR2","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin B et al (2015) Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 74(11):1983\u20131989. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205375","journal-title":"Ann Rheum Dis"},{"key":"9023_CR3","doi-asserted-by":"publisher","first-page":"865373","DOI":"10.3389\/fimmu.2022.865373","volume":"13","author":"M Casian","year":"2022","unstructured":"Casian M et al (2022) Cardiovascular disease in primary Sj\u00f6gren\u2019s syndrome: raising clinicians\u2019 awareness. Front Immunol 13:865373. https:\/\/doi.org\/10.3389\/fimmu.2022.865373","journal-title":"Front Immunol"},{"issue":"3","key":"9023_CR4","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.amjms.2022.12.007","volume":"365","author":"A Carvajal-Gonz\u00e1lez","year":"2023","unstructured":"Carvajal-Gonz\u00e1lez A et al (2023) Multiple fibrotic lung nodules in a patient with primary Sj\u00f6gren\u2019s syndrome. Am J Med Sci 365(3):302\u2013306. https:\/\/doi.org\/10.1016\/j.amjms.2022.12.007","journal-title":"Am J Med Sci"},{"key":"9023_CR5","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P et al (2016) Sj\u00f6gren syndrome. Nat Rev Dis Primers 2:16047. https:\/\/doi.org\/10.1038\/nrdp.2016.47","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"9023_CR6","first-page":"800","volume":"37","author":"G Hern\u00e1ndez-Molina","year":"2010","unstructured":"Hern\u00e1ndez-Molina G et al (2010) Similarities and differences between primary and secondary Sj\u00f6gren\u2019s syndrome. J Clin Invest 37(4):800\u2013808","journal-title":"J Clin Invest"},{"issue":"4","key":"9023_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.medcli.2022.10.007","volume":"160","author":"P Brito-Zer\u00f3n","year":"2023","unstructured":"Brito-Zer\u00f3n P, Retamozo S, Ramos-Casals M (2023) Sj\u00f6gren syndrome. Med Clin (Barc) 160(4):163\u2013171. https:\/\/doi.org\/10.1016\/j.medcli.2022.10.007","journal-title":"Med Clin (Barc)"},{"issue":"10","key":"9023_CR8","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/14728222.2022.2157259","volume":"26","author":"D Ridgewell","year":"2022","unstructured":"Ridgewell D, Thalayasingam N, Ng WF (2022) Sj\u00f6gren\u2019s syndrome: shedding light on emerging and key drug targets. Expert Opin Ther Targets 26(10):869\u2013882. https:\/\/doi.org\/10.1080\/14728222.2022.2157259","journal-title":"Expert Opin Ther Targets"},{"issue":"7","key":"9023_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1210\/er.2008-0024","volume":"29","author":"MA Cornier","year":"2008","unstructured":"Cornier MA et al (2008) The metabolic syndrome. Endocr Rev 29(7):777\u2013822. https:\/\/doi.org\/10.1210\/er.2008-0024","journal-title":"Endocr Rev"},{"issue":"3","key":"9023_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10067-015-3072-1","volume":"35","author":"KL Augusto","year":"2016","unstructured":"Augusto KL et al (2016) Metabolic syndrome in Sj\u00f6gren\u2019s syndrome patients: a relevant concern for clinical monitoring. Clin Rheumatol 35(3):639\u2013647. https:\/\/doi.org\/10.1007\/s10067-015-3072-1","journal-title":"Clin Rheumatol"},{"issue":"4","key":"9023_CR11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3390\/ijms18040836","volume":"18","author":"Y Shikama","year":"2017","unstructured":"Shikama Y et al (2017) Potential role of free fatty acids in the pathogenesis of periodontitis and primary Sj\u00f6gren\u2019s syndrome. Int J Mol Sci 18(4):836. https:\/\/doi.org\/10.3390\/ijms18040836","journal-title":"Int J Mol Sci"},{"issue":"2","key":"9023_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.2174\/1573397116666201211124815","volume":"17","author":"A Azarfar","year":"2021","unstructured":"Azarfar A, Ahmed A, B\u00e9g S (2021) Prevalence of anxiety, depression, sleep disturbance, fibromyalgia, obesity, and gastroesophageal disease in patients with rheumatic diseases. Curr Rheumatol Rev 17(2):252\u2013257. https:\/\/doi.org\/10.2174\/1573397116666201211124815","journal-title":"Curr Rheumatol Rev"},{"issue":"5","key":"9023_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrm.2017.138","volume":"19","author":"T Harayama","year":"2018","unstructured":"Harayama T, Riezman H (2018) Understanding the diversity of membrane lipid composition. Nat Rev Mol Cell Biol 19(5):281\u2013296. https:\/\/doi.org\/10.1038\/nrm.2017.138","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"9023_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrm.2017.16","volume":"18","author":"E Sezgin","year":"2017","unstructured":"Sezgin E et al (2017) The mystery of membrane organization: composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Biol 18(6):361\u2013374. https:\/\/doi.org\/10.1038\/nrm.2017.16","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"587","key":"9023_CR15","doi-asserted-by":"publisher","first-page":"eaaz6314","DOI":"10.1126\/scitranslmed.aaz6314","volume":"13","author":"X Liu","year":"2021","unstructured":"Liu X et al (2021) Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy. Sci Transl Med 13(587):eaaz6314. https:\/\/doi.org\/10.1126\/scitranslmed.aaz6314","journal-title":"Sci Transl Med"},{"issue":"18","key":"9023_CR16","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1038\/sj.emboj.7600798","volume":"24","author":"G van Meer","year":"2005","unstructured":"van Meer G (2005) Cellular lipidomics. EMBO J 24(18):3159\u20133165. https:\/\/doi.org\/10.1038\/sj.emboj.7600798","journal-title":"EMBO J"},{"issue":"8","key":"9023_CR17","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.cmet.2023.05.009","volume":"35","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) Molecular mechanisms of snoRNA-IL-15 crosstalk in adipocyte lipolysis and NK cell rejuvenation. Cell Metab 35(8):1457-1473.e13. https:\/\/doi.org\/10.1016\/j.cmet.2023.05.009","journal-title":"Cell Metab"},{"issue":"2","key":"9023_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/rheumatology\/kev266","volume":"55","author":"RW Gan","year":"2016","unstructured":"Gan RW et al (2016) Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: a nested case-control study. Rheumatology (Oxford) 55(2):367\u2013376. https:\/\/doi.org\/10.1093\/rheumatology\/kev266","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"9023_CR19","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3390\/nu14051030","volume":"14","author":"W Ta\u0144ski","year":"2022","unstructured":"Ta\u0144ski W et al (2022) The relationship between fatty acids and the development, course and treatment of rheumatoid arthritis. Nutrients 14(5):1030. https:\/\/doi.org\/10.3390\/nu14051030","journal-title":"Nutrients"},{"key":"9023_CR20","doi-asserted-by":"publisher","first-page":"103091","DOI":"10.1016\/j.jaut.2023.103091","volume":"139","author":"HR Bae","year":"2023","unstructured":"Bae HR et al (2023) Chronic inflammation in high-fat diet-fed mice: unveiling the early pathogenic connection between liver and adipose tissue. J Autoimmun 139:103091. https:\/\/doi.org\/10.1016\/j.jaut.2023.103091","journal-title":"J Autoimmun"},{"issue":"14","key":"9023_CR21","doi-asserted-by":"publisher","first-page":"11600","DOI":"10.3390\/ijms241411600","volume":"24","author":"JW Shou","year":"2023","unstructured":"Shou JW, Shaw PC (2023) Berberine reduces lipid accumulation in obesity via mediating transcriptional function of PPAR\u03b4. Int J Mol Sci 24(14):11600. https:\/\/doi.org\/10.3390\/ijms241411600","journal-title":"Int J Mol Sci"},{"issue":"3","key":"9023_CR22","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/rheumatology\/keaa456","volume":"60","author":"J Lu","year":"2021","unstructured":"Lu J et al (2021) Untargeted lipidomics reveals specific lipid abnormalities in Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford) 60(3):1252\u20131259. https:\/\/doi.org\/10.1093\/rheumatology\/keaa456","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"9023_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/rheumatology\/kei190","volume":"45","author":"BM Lodde","year":"2006","unstructured":"Lodde BM et al (2006) Serum lipid levels in Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford) 45(4):481\u2013484. https:\/\/doi.org\/10.1093\/rheumatology\/kei190","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"9023_CR24","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3899\/jrheum.090942","volume":"37","author":"JH Kang","year":"2010","unstructured":"Kang JH, Lin HC (2010) Comorbidities in patients with primary Sjogren\u2019s syndrome: a registry-based case-control study. J Rheumatol 37(6):1188\u20131194. https:\/\/doi.org\/10.3899\/jrheum.090942","journal-title":"J Rheumatol"},{"issue":"2","key":"9023_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/joim.12346","volume":"278","author":"E Bartoloni","year":"2015","unstructured":"Bartoloni E et al (2015) Cardiovascular disease risk burden in primary Sj\u00f6gren\u2019s syndrome: results of a population-based multicentre cohort study. J Intern Med 278(2):185\u2013192. https:\/\/doi.org\/10.1111\/joim.12346","journal-title":"J Intern Med"},{"issue":"1","key":"9023_CR26","first-page":"71","volume":"44","author":"X Cai","year":"2019","unstructured":"Cai X et al (2019) Risk of cardiovascular involvement in patients with primary Sj\u00f6gren\u2019s syndrome: a large-scale cross-sectional cohort study. Acta Reumatol Port 44(1):71\u201377","journal-title":"Acta Reumatol Port"},{"issue":"3","key":"9023_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.exer.2009.03.020","volume":"89","author":"K Wu","year":"2009","unstructured":"Wu K et al (2009) Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland. Exp Eye Res 89(3):319\u2013332. https:\/\/doi.org\/10.1016\/j.exer.2009.03.020","journal-title":"Exp Eye Res"},{"issue":"12","key":"9023_CR28","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1167\/iovs.04-1394","volume":"46","author":"P Aragona","year":"2005","unstructured":"Aragona P et al (2005) Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sj\u00f6gren\u2019s syndrome patients. Invest Ophthalmol Vis Sci 46(12):4474\u20134479. https:\/\/doi.org\/10.1167\/iovs.04-1394","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"9023_CR29","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1038\/s41467-022-30773-y","volume":"13","author":"B Khatri","year":"2022","unstructured":"Khatri B et al (2022) Genome-wide association study identifies Sj\u00f6gren\u2019s risk loci with functional implications in immune and glandular cells. Nat Commun 13(1):4287. https:\/\/doi.org\/10.1038\/s41467-022-30773-y","journal-title":"Nat Commun"},{"issue":"5","key":"9023_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41584-023-00932-6","volume":"19","author":"GE Thorlacius","year":"2023","unstructured":"Thorlacius GE, Bj\u00f6rk A, Wahren-Herlenius M (2023) Genetics and epigenetics of primary Sj\u00f6gren syndrome: implications for future therapies. Nat Rev Rheumatol 19(5):288\u2013306. https:\/\/doi.org\/10.1038\/s41584-023-00932-6","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"9023_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/joim.13032","volume":"287","author":"A Bj\u00f6rk","year":"2020","unstructured":"Bj\u00f6rk A, Mofors J, Wahren-Herlenius M (2020) Environmental factors in the pathogenesis of primary Sj\u00f6gren\u2019s syndrome. J Intern Med 287(5):475\u2013492. https:\/\/doi.org\/10.1111\/joim.13032","journal-title":"J Intern Med"},{"issue":"4","key":"9023_CR32","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/BOR.0b013e32836200d2","volume":"25","author":"A Igoe","year":"2013","unstructured":"Igoe A, Scofield RH (2013) Autoimmunity and infection in Sj\u00f6gren\u2019s syndrome. Curr Opin Rheumatol 25(4):480\u2013487. https:\/\/doi.org\/10.1097\/BOR.0b013e32836200d2","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"9023_CR33","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1002\/art.38726","volume":"66","author":"C Croia","year":"2014","unstructured":"Croia C et al (2014) Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol 66(9):2545\u20132557. https:\/\/doi.org\/10.1002\/art.38726","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"9023_CR34","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.55563\/clinexprheumatol\/255qsx","volume":"41","author":"S Longhino","year":"2023","unstructured":"Longhino S et al (2023) Sj\u00f6gren\u2019s syndrome: one year in review 2023. Clin Exp Rheumatol 41(12):2343\u20132356. https:\/\/doi.org\/10.55563\/clinexprheumatol\/255qsx","journal-title":"Clin Exp Rheumatol"},{"issue":"1\u20132","key":"9023_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jaut.2012.01.004","volume":"39","author":"YT Konttinen","year":"2012","unstructured":"Konttinen YT et al (2012) Sex steroids in Sj\u00f6gren\u2019s syndrome. J Autoimmun 39(1\u20132):49\u201356. https:\/\/doi.org\/10.1016\/j.jaut.2012.01.004","journal-title":"J Autoimmun"},{"issue":"5","key":"9023_CR36","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/art.23368","volume":"58","author":"US Deshmukh","year":"2008","unstructured":"Deshmukh US et al (2008) Inflammatory stimuli accelerate Sj\u00f6gren\u2019s syndrome-like disease in (NZB x NZW)F1 mice. Arthritis Rheum 58(5):1318\u20131323. https:\/\/doi.org\/10.1002\/art.23368","journal-title":"Arthritis Rheum"},{"issue":"1","key":"9023_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13075-017-1385-y","volume":"19","author":"C Alessandri","year":"2017","unstructured":"Alessandri C et al (2017) CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sj\u00f6gren\u2019s syndrome patients and correlates with focus score and disease activity. Arthritis Res Ther 19(1):178. https:\/\/doi.org\/10.1186\/s13075-017-1385-y","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"9023_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12016-007-8011-8","volume":"32","author":"GE Katsifis","year":"2007","unstructured":"Katsifis GE, Moutsopoulos NM, Wahl SM (2007) T lymphocytes in Sj\u00f6gren\u2019s syndrome: contributors to and regulators of pathophysiology. Clin Rev Allergy Immunol 32(3):252\u2013264. https:\/\/doi.org\/10.1007\/s12016-007-8011-8","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"9023_CR39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/ar2210","volume":"9","author":"A Hansen","year":"2007","unstructured":"Hansen A, Lipsky PE, D\u00f6rner T (2007) B cells in Sj\u00f6gren\u2019s syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther 9(4):218. https:\/\/doi.org\/10.1186\/ar2210","journal-title":"Arthritis Res Ther"},{"key":"9023_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/128_2014_582","volume":"362","author":"A Yang","year":"2015","unstructured":"Yang A, Zhao L, Wu YW (2015) Chemical synthesis and biological function of lipidated proteins. Top Curr Chem 362:137\u2013182. https:\/\/doi.org\/10.1007\/128_2014_582","journal-title":"Top Curr Chem"},{"issue":"1","key":"9023_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2005.10.024","volume":"186","author":"CR Sirtori","year":"2006","unstructured":"Sirtori CR, Fumagalli R (2006) LDL-cholesterol lowering or HDL-cholesterol raising for cardiovascular prevention. A lesson from cholesterol turnover studies and others. Atherosclerosis 186(1):1\u201311. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2005.10.024","journal-title":"Atherosclerosis"},{"key":"9023_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223315","author":"N Conrad","year":"2022","unstructured":"Conrad N et al (2022) Patients with a range of rheumatic diseases are at increased risk of cardiovascular disorders towards a re-evaluation of the European League Against Rheumatism (EULAR)\u2019s recommendations for cardiovascular risk management? Ann Rheum Dis. https:\/\/doi.org\/10.1136\/ard-2022-223315","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"9023_CR43","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/09612033221147471","volume":"32","author":"N Bello","year":"2023","unstructured":"Bello N et al (2023) Cardiovascular events and risk in patients with systemic lupus erythematosus: systematic literature review and meta-analysis. Lupus 32(3):325\u2013341. https:\/\/doi.org\/10.1177\/09612033221147471","journal-title":"Lupus"},{"issue":"6","key":"9023_CR44","first-page":"324","volume":"155","author":"S Oresk\u00e1","year":"2016","unstructured":"Oresk\u00e1 S, Tom\u010d\u00edk M (2016) Cardiovascular risk in rheumatic diseases. Cas Lek Cesk 155(6):324\u2013332","journal-title":"Cas Lek Cesk"},{"issue":"2","key":"9023_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jbspin.2010.07.016","volume":"78","author":"JF Boyer","year":"2011","unstructured":"Boyer JF et al (2011) Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine 78(2):179\u2013183. https:\/\/doi.org\/10.1016\/j.jbspin.2010.07.016","journal-title":"Joint Bone Spine"},{"issue":"8","key":"9023_CR46","doi-asserted-by":"publisher","first-page":"371","DOI":"10.5483\/BMBRep.2018.51.8.171","volume":"51","author":"H Ryu","year":"2018","unstructured":"Ryu H, Chung Y (2018) Dyslipidemia promotes germinal center reactions via IL-27. BMB Rep 51(8):371\u2013372. https:\/\/doi.org\/10.5483\/BMBRep.2018.51.8.171","journal-title":"BMB Rep"},{"issue":"6","key":"9023_CR47","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1172\/jci92217","volume":"127","author":"S Bagchi","year":"2017","unstructured":"Bagchi S et al (2017) CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice. J Clin Invest 127(6):2339\u20132352. https:\/\/doi.org\/10.1172\/jci92217","journal-title":"J Clin Invest"},{"issue":"23","key":"9023_CR48","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.2174\/0929867322666150520095008","volume":"22","author":"A Papapanagiotou","year":"2015","unstructured":"Papapanagiotou A et al (2015) Novel inflammatory markers in hyperlipidemia: clinical implications. Curr Med Chem 22(23):2727\u20132743. https:\/\/doi.org\/10.2174\/0929867322666150520095008","journal-title":"Curr Med Chem"},{"issue":"1","key":"9023_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13075-022-02781-2","volume":"24","author":"J Sigaux","year":"2022","unstructured":"Sigaux J et al (2022) Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis. Arthritis Res Ther 24(1):100. https:\/\/doi.org\/10.1186\/s13075-022-02781-2","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"9023_CR50","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3390\/nu16121974","volume":"16","author":"B Wang","year":"2024","unstructured":"Wang B et al (2024) Association between unsaturated fatty acid-type diet and systemic lupus erythematosus: a systematic review with meta-analyses. Nutrients 16(12):1974. https:\/\/doi.org\/10.3390\/nu16121974","journal-title":"Nutrients"},{"issue":"5","key":"9023_CR51","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cmet.2023.03.010","volume":"35","author":"Q Zeng","year":"2023","unstructured":"Zeng Q et al (2023) Spleen fibroblastic reticular cell-derived acetylcholine promotes lipid metabolism to drive autoreactive B cell responses. Cell Metab 35(5):837-854.e8. https:\/\/doi.org\/10.1016\/j.cmet.2023.03.010","journal-title":"Cell Metab"},{"issue":"Suppl 6","key":"9023_CR52","doi-asserted-by":"publisher","first-page":"vi53","DOI":"10.1093\/rheumatology\/keab466","volume":"60","author":"N Thalayasingam","year":"2021","unstructured":"Thalayasingam N et al (2021) New developments in Sjogren\u2019s syndrome. Rheumatology (Oxford) 60(Suppl 6):vi53\u2013vi61. https:\/\/doi.org\/10.1093\/rheumatology\/keab466","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"9023_CR53","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1002\/art.21475","volume":"52","author":"G Vaudo","year":"2005","unstructured":"Vaudo G et al (2005) Precocious intima-media thickening in patients with primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 52(12):3890\u20133897. https:\/\/doi.org\/10.1002\/art.21475","journal-title":"Arthritis Rheum"},{"key":"9023_CR54","doi-asserted-by":"publisher","unstructured":"Gerli R et al (2006) Traditional cardiovascular risk factors in primary Sj\u00f6gren\u2019s syndrome--role of dyslipidaemia. Rheumatology (Oxford) 45(12):1580-1; author reply 1581-2.https:\/\/doi.org\/10.1093\/rheumatology\/kel349","DOI":"10.1093\/rheumatology\/kel349"},{"issue":"4","key":"9023_CR55","first-page":"754","volume":"34","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M et al (2007) High prevalence of serum metabolic alterations in primary Sj\u00f6gren\u2019s syndrome: influence on clinical and immunological expression. J Rheumatol 34(4):754\u2013761","journal-title":"J Rheumatol"},{"issue":"3","key":"9023_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jbspin.2010.02.011","volume":"77","author":"W Cruz","year":"2010","unstructured":"Cruz W et al (2010) Is there a link between inflammation and abnormal lipoprotein profile in Sj\u00f6gren\u2019s syndrome? Joint Bone Spine 77(3):229\u2013231. https:\/\/doi.org\/10.1016\/j.jbspin.2010.02.011","journal-title":"Joint Bone Spine"},{"issue":"8","key":"9023_CR57","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/0961203310367504","volume":"19","author":"M P\u00e9rez-De-Lis","year":"2010","unstructured":"P\u00e9rez-De-Lis M et al (2010) Cardiovascular risk factors in primary Sj\u00f6gren\u2019s syndrome: a case-control study in 624 patients. Lupus 19(8):941\u2013948. https:\/\/doi.org\/10.1177\/0961203310367504","journal-title":"Lupus"},{"issue":"2","key":"9023_CR58","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.rcreu.2021.08.001","volume":"30","author":"PA Quevedo Mayorga","year":"2023","unstructured":"Quevedo Mayorga PA et al (2023) Caracterizaci\u00f3n del perfil lip\u00eddico en pacientes con s\u00edndrome de Sj\u00f6gren primario. Rev Colomb Reumatol 30(2):102\u2013109. https:\/\/doi.org\/10.1016\/j.rcreu.2021.08.001","journal-title":"Rev Colomb Reumatol"},{"key":"9023_CR59","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06686-6","author":"CS Santos","year":"2023","unstructured":"Santos CS et al (2023) Risk factors for cardiovascular disease in primary Sj\u00f6gren\u2019s syndrome (pSS): a 20-year follow-up study. Clin Rheumatol. https:\/\/doi.org\/10.1007\/s10067-023-06686-6","journal-title":"Clin Rheumatol"},{"key":"9023_CR60","doi-asserted-by":"publisher","first-page":"123432","DOI":"10.1016\/j.jchromb.2022.123432","volume":"1210","author":"R Nagatomo","year":"2022","unstructured":"Nagatomo R et al (2022) Short-chain fatty acids profiling in biological samples from a mouse model of Sj\u00f6gren\u2019s syndrome based on derivatized LC-MS\/MS assay. J Chromatogr B Analyt Technol Biomed Life Sci 1210:123432. https:\/\/doi.org\/10.1016\/j.jchromb.2022.123432","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"5","key":"9023_CR61","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/acr.22227","volume":"66","author":"M Juarez","year":"2014","unstructured":"Juarez M et al (2014) Cardiovascular risk factors in women with primary Sj\u00f6gren\u2019s syndrome: United Kingdom primary Sj\u00f6gren\u2019s syndrome registry results. Arthritis Care Res (Hoboken) 66(5):757\u2013764. https:\/\/doi.org\/10.1002\/acr.22227","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"9023_CR62","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1093\/rheumatology\/kead115","volume":"62","author":"SS Zhao","year":"2023","unstructured":"Zhao SS, Dyball S (2023) Cholesteryl ester transfer protein inhibition is associated with reduced risk of Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford) 62(9):e258\u2013e259. https:\/\/doi.org\/10.1093\/rheumatology\/kead115","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"9023_CR63","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.rcreue.2021.08.003","volume":"30","author":"PA Quevedo Mayorga","year":"2023","unstructured":"Quevedo Mayorga PA et al (2023) Characterization of the lipid profile in patients with primary Sj\u00f6gren\u2019s syndrome. Rev Colomb Reumatol 30(2):102\u2013109. https:\/\/doi.org\/10.1016\/j.rcreue.2021.08.003","journal-title":"Rev Colomb Reumatol"},{"key":"9023_CR64","doi-asserted-by":"publisher","first-page":"106865","DOI":"10.1016\/j.imlet.2024.106865","volume":"267","author":"L Yang","year":"2024","unstructured":"Yang L et al (2024) Dysregulated serum lipid profile is associated with inflammation and disease activity in primary Sj\u00f6gren\u2019s syndrome: a retrospective study in China. Immunol Lett 267:106865. https:\/\/doi.org\/10.1016\/j.imlet.2024.106865","journal-title":"Immunol Lett"},{"issue":"2","key":"9023_CR65","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.survophthal.2019.10.004","volume":"65","author":"O Bjordal","year":"2020","unstructured":"Bjordal O et al (2020) Primary Sj\u00f6gren\u2019s syndrome and the eye. Surv Ophthalmol 65(2):119\u2013132. https:\/\/doi.org\/10.1016\/j.survophthal.2019.10.004","journal-title":"Surv Ophthalmol"},{"issue":"17","key":"9023_CR66","doi-asserted-by":"publisher","first-page":"10051","DOI":"10.3390\/ijms231710051","volume":"23","author":"DD Muntean","year":"2022","unstructured":"Muntean DD et al (2022) The diagnostic value of MRI-based radiomic analysis of lacrimal glands in patients with Sj\u00f6gren\u2019s syndrome. Int J Mol Sci 23(17):10051. https:\/\/doi.org\/10.3390\/ijms231710051","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9023_CR67","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/02713680500428613","volume":"31","author":"C Ding","year":"2006","unstructured":"Ding C et al (2006) Unique ultrastructure of exorbital lacrimal glands in male NOD and BALB\/c mice. Curr Eye Res 31(1):13\u201322. https:\/\/doi.org\/10.1080\/02713680500428613","journal-title":"Curr Eye Res"},{"issue":"12","key":"9023_CR68","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1016\/j.ajpath.2020.09.002","volume":"190","author":"X He","year":"2020","unstructured":"He X et al (2020) High-fat diet-induced functional and pathologic changes in lacrimal gland. Am J Pathol 190(12):2387\u20132402. https:\/\/doi.org\/10.1016\/j.ajpath.2020.09.002","journal-title":"Am J Pathol"},{"issue":"16","key":"9023_CR69","doi-asserted-by":"publisher","first-page":"8997","DOI":"10.3390\/ijms22168997","volume":"22","author":"F Fineide","year":"2021","unstructured":"Fineide F et al (2021) Characterization of lipids in saliva, tears and minor salivary glands of Sj\u00f6gren\u2019s syndrome patients using an HPLC\/MS-based approach. Int J Mol Sci 22(16):8997. https:\/\/doi.org\/10.3390\/ijms22168997","journal-title":"Int J Mol Sci"},{"issue":"2","key":"9023_CR70","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cei.12683","volume":"182","author":"G Kageyama","year":"2015","unstructured":"Kageyama G et al (2015) Metabolomics analysis of saliva from patients with primary Sj\u00f6gren\u2019s syndrome. Clin Exp Immunol 182(2):149\u2013153. https:\/\/doi.org\/10.1111\/cei.12683","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"9023_CR71","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/metabo11090595","volume":"11","author":"M Herrala","year":"2021","unstructured":"Herrala M et al (2021) Low-dose doxycycline treatment normalizes levels of some salivary metabolites associated with oral microbiota in patients with primary Sj\u00f6gren\u2019s syndrome. Metabolites 11(9):595. https:\/\/doi.org\/10.3390\/metabo11090595","journal-title":"Metabolites"},{"issue":"1","key":"9023_CR72","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2334\/josnusd.19-0504","volume":"63","author":"M Herrala","year":"2020","unstructured":"Herrala M et al (2020) Variability of salivary metabolite levels in patients with Sj\u00f6gren\u2019s syndrome. J Oral Sci 63(1):22\u201326. https:\/\/doi.org\/10.2334\/josnusd.19-0504","journal-title":"J Oral Sci"},{"key":"9023_CR73","doi-asserted-by":"publisher","first-page":"108713","DOI":"10.1016\/j.exer.2021.108713","volume":"210","author":"A Ewurum","year":"2021","unstructured":"Ewurum A et al (2021) A spectroscopic approach to measuring meibum lipid composition and conformation in donors with Sj\u04e7gren\u2019s syndrome. Exp Eye Res 210:108713. https:\/\/doi.org\/10.1016\/j.exer.2021.108713","journal-title":"Exp Eye Res"},{"key":"9023_CR74","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jtos.2021.07.006","volume":"22","author":"G Urbanski","year":"2021","unstructured":"Urbanski G et al (2021) Tear metabolomics highlights new potential biomarkers for differentiating between Sj\u00f6gren\u2019s syndrome and other causes of dry eye. Ocul Surf 22:110\u2013116. https:\/\/doi.org\/10.1016\/j.jtos.2021.07.006","journal-title":"Ocul Surf"},{"key":"9023_CR75","doi-asserted-by":"publisher","first-page":"100459","DOI":"10.1016\/j.clinsp.2024.100459","volume":"79","author":"G Piacenza Florezi","year":"2024","unstructured":"Piacenza Florezi G et al (2024) Targeted saliva metabolomics in Sj\u00f6gren\u2019s syndrome. Clinics (Sao Paulo) 79:100459. https:\/\/doi.org\/10.1016\/j.clinsp.2024.100459","journal-title":"Clinics (Sao Paulo)"},{"issue":"12","key":"9023_CR76","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.tcb.2020.09.006","volume":"30","author":"J Yan","year":"2020","unstructured":"Yan J, Horng T (2020) Lipid metabolism in regulation of macrophage functions. Trends Cell Biol 30(12):979\u2013989. https:\/\/doi.org\/10.1016\/j.tcb.2020.09.006","journal-title":"Trends Cell Biol"},{"issue":"1","key":"9023_CR77","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/imr.12848","volume":"295","author":"N van Teijlingen Bakker","year":"2020","unstructured":"van Teijlingen Bakker N, Pearce EJ (2020) Cell-intrinsic metabolic regulation of mononuclear phagocyte activation: findings from the tip of the iceberg. Immunol Rev 295(1):54\u201367. https:\/\/doi.org\/10.1111\/imr.12848","journal-title":"Immunol Rev"},{"issue":"9","key":"9023_CR78","doi-asserted-by":"publisher","first-page":"30743","DOI":"10.3390\/ijms21093074","volume":"21","author":"MD Cas","year":"2020","unstructured":"Cas MD et al (2020) Functional lipids in autoimmune inflammatory diseases. Int J Mol Sci 21(9):30743. https:\/\/doi.org\/10.3390\/ijms21093074","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9023_CR79","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.it.2021.11.007","volume":"43","author":"RJ King","year":"2022","unstructured":"King RJ, Singh PK, Mehla K (2022) The cholesterol pathway: impact on immunity and cancer. Trends Immunol 43(1):78\u201392. https:\/\/doi.org\/10.1016\/j.it.2021.11.007","journal-title":"Trends Immunol"},{"issue":"1","key":"9023_CR80","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imm.12617","volume":"149","author":"P Varshney","year":"2016","unstructured":"Varshney P, Yadav V, Saini N (2016) Lipid rafts in immune signalling: current progress and future perspective. Immunology 149(1):13\u201324. https:\/\/doi.org\/10.1111\/imm.12617","journal-title":"Immunology"},{"issue":"12","key":"9023_CR81","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1093\/emboj\/cdg293","volume":"22","author":"K Saeki","year":"2003","unstructured":"Saeki K et al (2003) The B cell-specific major raft protein, raftlin, is necessary for the integrity of lipid raft and BCR signal transduction. EMBO J 22(12):3015\u20133026. https:\/\/doi.org\/10.1093\/emboj\/cdg293","journal-title":"EMBO J"},{"issue":"1","key":"9023_CR82","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.atherosclerosis.2012.07.029","volume":"225","author":"SH Wang","year":"2012","unstructured":"Wang SH et al (2012) HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells. Atherosclerosis 225(1):105\u2013114. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.07.029","journal-title":"Atherosclerosis"},{"issue":"13","key":"9023_CR83","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3390\/cells12131800","volume":"12","author":"L Jia","year":"2023","unstructured":"Jia L et al (2023) Mitochondrial control for healthy and autoimmune T cells. Cells 12(13):1800. https:\/\/doi.org\/10.3390\/cells12131800","journal-title":"Cells"},{"key":"9023_CR84","doi-asserted-by":"publisher","first-page":"112224","DOI":"10.1016\/j.biopha.2021.112224","volume":"143","author":"TM Nyambuya","year":"2021","unstructured":"Nyambuya TM et al (2021) The pleotropic effects of fluvastatin on complement-mediated T-cell activation in hypercholesterolemia. Biomed Pharmacother 143:112224. https:\/\/doi.org\/10.1016\/j.biopha.2021.112224","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"9023_CR85","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/ni.2570","volume":"14","author":"Y Kidani","year":"2013","unstructured":"Kidani Y et al (2013) Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity. Nat Immunol 14(5):489\u2013499. https:\/\/doi.org\/10.1038\/ni.2570","journal-title":"Nat Immunol"},{"issue":"2","key":"9023_CR86","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/s1474-4422(15)00334-8","volume":"15","author":"R Hohlfeld","year":"2016","unstructured":"Hohlfeld R et al (2016) The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets. Lancet Neurol 15(2):198\u2013209. https:\/\/doi.org\/10.1016\/s1474-4422(15)00334-8","journal-title":"Lancet Neurol"},{"issue":"3","key":"9023_CR87","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jaut.2012.05.019","volume":"39","author":"N Singh","year":"2012","unstructured":"Singh N, Cohen PL (2012) The T cell in Sjogren\u2019s syndrome: force majeure, not spectateur. J Autoimmun 39(3):229\u2013233. https:\/\/doi.org\/10.1016\/j.jaut.2012.05.019","journal-title":"J Autoimmun"},{"key":"9023_CR88","doi-asserted-by":"publisher","first-page":"593103","DOI":"10.3389\/fimmu.2020.593103","volume":"11","author":"S Iwata","year":"2020","unstructured":"Iwata S et al (2020) Enhanced fatty acid synthesis leads to subset imbalance and IFN-\u03b3 overproduction in T helper 1 cells. Front Immunol 11:593103. https:\/\/doi.org\/10.3389\/fimmu.2020.593103","journal-title":"Front Immunol"},{"issue":"6","key":"9023_CR89","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1172\/jci97785","volume":"128","author":"JD Proto","year":"2018","unstructured":"Proto JD et al (2018) Hypercholesterolemia induces T cell expansion in humanized immune mice. J Clin Invest 128(6):2370\u20132375. https:\/\/doi.org\/10.1172\/jci97785","journal-title":"J Clin Invest"},{"key":"9023_CR90","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00939-5","author":"J Yin","year":"2022","unstructured":"Yin J et al (2022) CYP51-mediated cholesterol biosynthesis is required for the proliferation of CD4+ T cells in Sjogren\u2019s syndrome. Clin Exp Med. https:\/\/doi.org\/10.1007\/s10238-022-00939-5","journal-title":"Clin Exp Med"},{"issue":"3","key":"9023_CR91","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/08916934.2018.1446525","volume":"51","author":"LA Aqrawi","year":"2018","unstructured":"Aqrawi LA et al (2018) Signalling pathways identified in salivary glands from primary Sj\u00f6gren\u2019s syndrome patients reveal enhanced adipose tissue development. Autoimmunity 51(3):135\u2013146. https:\/\/doi.org\/10.1080\/08916934.2018.1446525","journal-title":"Autoimmunity"},{"issue":"11","key":"9023_CR92","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/nm.3704","volume":"20","author":"L Berod","year":"2014","unstructured":"Berod L et al (2014) De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat Med 20(11):1327\u20131333. https:\/\/doi.org\/10.1038\/nm.3704","journal-title":"Nat Med"},{"issue":"12","key":"9023_CR93","doi-asserted-by":"publisher","first-page":"7625","DOI":"10.4049\/jimmunol.0804192","volume":"182","author":"B Li","year":"2009","unstructured":"Li B et al (2009) Regulation of Th17 differentiation by epidermal fatty acid-binding protein. J Immunol 182(12):7625\u20137633. https:\/\/doi.org\/10.4049\/jimmunol.0804192","journal-title":"J Immunol"},{"key":"9023_CR94","doi-asserted-by":"publisher","first-page":"602823","DOI":"10.3389\/fimmu.2020.602823","volume":"11","author":"H Zhou","year":"2020","unstructured":"Zhou H et al (2020) CD8+ T lymphocytes: crucial players in Sj\u00f6gren\u2019s syndrome. Front Immunol 11:602823. https:\/\/doi.org\/10.3389\/fimmu.2020.602823","journal-title":"Front Immunol"},{"issue":"3","key":"9023_CR95","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/bf00272434","volume":"8","author":"P Youinou","year":"1988","unstructured":"Youinou P et al (1988) Activation of peripheral blood lymphocytes in patients with primary Sj\u00f6gren\u2019s syndrome. Rheumatol Int 8(3):125\u2013130. https:\/\/doi.org\/10.1007\/bf00272434","journal-title":"Rheumatol Int"},{"key":"9023_CR96","doi-asserted-by":"publisher","unstructured":"Xu T et al (2023) Single-cell profiling reveals pathogenic role and differentiation trajectory of granzyme K+CD8+ T cells in primary Sj\u00f6gren\u2019s syndrome. JCI Insight 8(8). https:\/\/doi.org\/10.1172\/jci.insight.167490","DOI":"10.1172\/jci.insight.167490"},{"issue":"1","key":"9023_CR97","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.immuni.2014.06.005","volume":"41","author":"D O\u2019Sullivan","year":"2014","unstructured":"O\u2019Sullivan D et al (2014) Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity 41(1):75\u201388. https:\/\/doi.org\/10.1016\/j.immuni.2014.06.005","journal-title":"Immunity"},{"issue":"2","key":"9023_CR98","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.immuni.2019.06.002","volume":"51","author":"A Bachem","year":"2019","unstructured":"Bachem A et al (2019) Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8+ T cells. Immunity 51(2):285-297.e5. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.002","journal-title":"Immunity"},{"issue":"13","key":"9023_CR99","doi-asserted-by":"publisher","first-page":"11179","DOI":"10.3390\/ijms241311179","volume":"24","author":"Y Yura","year":"2023","unstructured":"Yura Y, Hamada M (2023) Outline of salivary gland pathogenesis of Sj\u00f6gren\u2019s syndrome and current therapeutic approaches. Int J Mol Sci 24(13):11179. https:\/\/doi.org\/10.3390\/ijms241311179","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9023_CR100","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/art.21478","volume":"54","author":"F d\u2019Arbonneau","year":"2006","unstructured":"d\u2019Arbonneau F et al (2006) BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sj\u00f6gren\u2019s syndrome. Arthritis Rheum 54(1):115\u2013126. https:\/\/doi.org\/10.1002\/art.21478","journal-title":"Arthritis Rheum"},{"issue":"3","key":"9023_CR101","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.4049\/jimmunol.165.3.1220","volume":"165","author":"RJ Petrie","year":"2000","unstructured":"Petrie RJ et al (2000) Transient translocation of the B cell receptor and Src homology 2 domain-containing inositol phosphatase to lipid rafts: evidence toward a role in calcium regulation. J Immunol 165(3):1220\u20131227. https:\/\/doi.org\/10.4049\/jimmunol.165.3.1220","journal-title":"J Immunol"},{"issue":"1","key":"9023_CR102","doi-asserted-by":"publisher","first-page":"108601","DOI":"10.1016\/j.celrep.2020.108601","volume":"34","author":"X Zhou","year":"2021","unstructured":"Zhou X et al (2021) Stearoyl-CoA desaturase-mediated monounsaturated fatty acid availability supports humoral immunity. Cell Rep 34(1):108601. https:\/\/doi.org\/10.1016\/j.celrep.2020.108601","journal-title":"Cell Rep"},{"issue":"11","key":"9023_CR103","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1182\/blood-2005-12-4788","volume":"107","author":"CA Doughty","year":"2006","unstructured":"Doughty CA et al (2006) Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 107(11):4458\u20134465. https:\/\/doi.org\/10.1182\/blood-2005-12-4788","journal-title":"Blood"},{"key":"9023_CR104","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cytogfr.2023.06.008","volume":"73","author":"X Ji","year":"2023","unstructured":"Ji X et al (2023) Lipid metabolism in regulation of B cell development and autoimmunity. Cytokine Growth Factor Rev 73:40\u201351. https:\/\/doi.org\/10.1016\/j.cytogfr.2023.06.008","journal-title":"Cytokine Growth Factor Rev"},{"issue":"14","key":"9023_CR105","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1177\/0961203320966385","volume":"29","author":"Y Tanaka","year":"2020","unstructured":"Tanaka Y et al (2020) Amiselimod, a sphingosine 1-phosphate receptor-1 modulator, for systemic lupus erythematosus: a multicenter, open-label exploratory study. Lupus 29(14):1902\u20131913. https:\/\/doi.org\/10.1177\/0961203320966385","journal-title":"Lupus"},{"key":"9023_CR106","doi-asserted-by":"publisher","unstructured":"(2020) Correction: First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study. Lupus Sci Med 7(1). https:\/\/doi.org\/10.1136\/lupus-2019-000354corr1","DOI":"10.1136\/lupus-2019-000354corr1"},{"issue":"2","key":"9023_CR107","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.immuni.2009.06.018","volume":"31","author":"N A-Gonzalez","year":"2009","unstructured":"A-Gonzalez N et al (2009) Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31(2):245\u2013258. https:\/\/doi.org\/10.1016\/j.immuni.2009.06.018","journal-title":"Immunity"},{"issue":"7\u20138","key":"9023_CR108","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/08916934.2019.1684475","volume":"52","author":"K Skarstein","year":"2019","unstructured":"Skarstein K et al (2019) Autoantigen-specific B cells and plasma cells are prominent in areas of fatty infiltration in salivary glands of patients with primary Sj\u00f6gren\u2019s syndrome. Autoimmunity 52(7\u20138):242\u2013250. https:\/\/doi.org\/10.1080\/08916934.2019.1684475","journal-title":"Autoimmunity"},{"issue":"5","key":"9023_CR109","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"issue":"3","key":"9023_CR110","doi-asserted-by":"publisher","first-page":"188890","DOI":"10.1016\/j.bbcan.2023.188890","volume":"1878","author":"Y Liu","year":"2023","unstructured":"Liu Y et al (2023) GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment. Biochim Biophys Acta Rev Cancer 1878(3):188890. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188890","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"9023_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2024.04.003","volume":"218","author":"J Zhou","year":"2024","unstructured":"Zhou J et al (2024) Downregulated GPX4 in salivary gland epithelial cells contributes to salivary secretion dysfunction in Sjogren\u2019s syndrome via lipid ROS\/pSTAT4\/AQP5 axis. Free Radic Biol Med 218:1\u201315. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.04.003","journal-title":"Free Radic Biol Med"},{"key":"9023_CR112","doi-asserted-by":"publisher","first-page":"5080843","DOI":"10.1155\/2019\/5080843","volume":"2019","author":"LJ Su","year":"2019","unstructured":"Su LJ et al (2019) Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis. Oxid Med Cell Longev 2019:5080843. https:\/\/doi.org\/10.1155\/2019\/5080843","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"9023_CR113","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/0022034513487378","volume":"92","author":"Y Shikama","year":"2013","unstructured":"Shikama Y et al (2013) Effects of free fatty acids on human salivary gland epithelial cells. J Dent Res 92(6):540\u2013546. https:\/\/doi.org\/10.1177\/0022034513487378","journal-title":"J Dent Res"},{"issue":"10","key":"9023_CR114","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/j.1440-1827.2005.01882.x","volume":"55","author":"Y Toda","year":"2005","unstructured":"Toda Y et al (2005) Detection of ABCA7-positive cells in salivary glands from patients with Sj\u00f6gren\u2019s syndrome. Pathol Int 55(10):639\u2013643. https:\/\/doi.org\/10.1111\/j.1440-1827.2005.01882.x","journal-title":"Pathol Int"},{"issue":"1","key":"9023_CR115","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/eji.200425406","volume":"35","author":"M Harangi","year":"2005","unstructured":"Harangi M et al (2005) Homozygosity for the 168His variant of the minor histocompatibility antigen HA-1 is associated with reduced risk of primary Sj\u00f6gren\u2019s syndrome. Eur J Immunol 35(1):305\u2013317. https:\/\/doi.org\/10.1002\/eji.200425406","journal-title":"Eur J Immunol"},{"issue":"4","key":"9023_CR116","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","volume":"34","author":"MI Christodoulou","year":"2010","unstructured":"Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM (2010) Characteristics of the minor salivary gland infiltrates in Sj\u00f6gren\u2019s syndrome. J Autoimmun 34(4):400\u2013407. https:\/\/doi.org\/10.1016\/j.jaut.2009.10.004","journal-title":"J Autoimmun"},{"issue":"9","key":"9023_CR117","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1172\/jci15593","volume":"109","author":"JD Horton","year":"2002","unstructured":"Horton JD, Goldstein JL, Brown MS (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109(9):1125\u20131131. https:\/\/doi.org\/10.1172\/jci15593","journal-title":"J Clin Invest"},{"key":"9023_CR118","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.3389\/fimmu.2019.02993","volume":"10","author":"A Batista-Gonzalez","year":"2019","unstructured":"Batista-Gonzalez A et al (2019) New insights on the role of lipid metabolism in the metabolic reprogramming of macrophages. Front Immunol 10:2993. https:\/\/doi.org\/10.3389\/fimmu.2019.02993","journal-title":"Front Immunol"},{"issue":"2","key":"9023_CR119","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1172\/jci78253","volume":"125","author":"JS Moon","year":"2015","unstructured":"Moon JS et al (2015) UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis. J Clin Invest 125(2):665\u2013680. https:\/\/doi.org\/10.1172\/jci78253","journal-title":"J Clin Invest"},{"key":"9023_CR120","doi-asserted-by":"publisher","first-page":"101993","DOI":"10.1016\/j.arr.2023.101993","volume":"90","author":"S Xue","year":"2023","unstructured":"Xue S, Su Z, Liu D (2023) Immunometabolism and immune response regulate macrophage function in atherosclerosis. Ageing Res Rev 90:101993. https:\/\/doi.org\/10.1016\/j.arr.2023.101993","journal-title":"Ageing Res Rev"},{"issue":"3","key":"9023_CR121","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cmet.2007.02.001","volume":"5","author":"MA Lazar","year":"2007","unstructured":"Lazar MA, Willson TM (2007) Sweet dreams for LXR. Cell Metab 5(3):159\u2013161. https:\/\/doi.org\/10.1016\/j.cmet.2007.02.001","journal-title":"Cell Metab"},{"issue":"1","key":"9023_CR122","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.molcel.2006.11.022","volume":"25","author":"S Ghisletti","year":"2007","unstructured":"Ghisletti S et al (2007) Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. Mol Cell 25(1):57\u201370. https:\/\/doi.org\/10.1016\/j.molcel.2006.11.022","journal-title":"Mol Cell"},{"issue":"3","key":"9023_CR123","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1172\/jci27883","volume":"116","author":"N Zelcer","year":"2006","unstructured":"Zelcer N, Tontonoz P (2006) Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 116(3):607\u2013614. https:\/\/doi.org\/10.1172\/jci27883","journal-title":"J Clin Invest"},{"issue":"2","key":"9023_CR124","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nm820","volume":"9","author":"SB Joseph","year":"2003","unstructured":"Joseph SB et al (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9(2):213\u2013219. https:\/\/doi.org\/10.1038\/nm820","journal-title":"Nat Med"},{"issue":"3","key":"9023_CR125","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1194\/jlr.M010686","volume":"52","author":"C Hong","year":"2011","unstructured":"Hong C et al (2011) Constitutive activation of LXR in macrophages regulates metabolic and inflammatory gene expression: identification of ARL7 as a direct target. J Lipid Res 52(3):531\u2013539. https:\/\/doi.org\/10.1194\/jlr.M010686","journal-title":"J Lipid Res"},{"key":"9023_CR126","doi-asserted-by":"publisher","first-page":"102510","DOI":"10.1016\/j.jaut.2020.102510","volume":"113","author":"Y Liu","year":"2020","unstructured":"Liu Y et al (2020) The roles of PPAR\u03b3 and its agonists in autoimmune diseases: a comprehensive review. J Autoimmun 113:102510. https:\/\/doi.org\/10.1016\/j.jaut.2020.102510","journal-title":"J Autoimmun"},{"issue":"4","key":"9023_CR127","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2337\/diabetes.47.4.507","volume":"47","author":"BM Spiegelman","year":"1998","unstructured":"Spiegelman BM (1998) PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47(4):507\u2013514. https:\/\/doi.org\/10.2337\/diabetes.47.4.507","journal-title":"Diabetes"},{"key":"9023_CR128","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jaut.2017.09.007","volume":"86","author":"AG Vakrakou","year":"2018","unstructured":"Vakrakou AG et al (2018) Impaired anti-inflammatory activity of PPAR\u03b3 in the salivary epithelia of Sj\u00f6gren\u2019s syndrome patients imposed by intrinsic NF-\u03baB activation. J Autoimmun 86:62\u201374. https:\/\/doi.org\/10.1016\/j.jaut.2017.09.007","journal-title":"J Autoimmun"},{"issue":"6","key":"9023_CR129","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/iovs.63.6.12","volume":"63","author":"X Guo","year":"2022","unstructured":"Guo X et al (2022) PPAR-\u03b1 agonist fenofibrate ameliorates sj\u00f6gren syndrome-like dacryoadenitis by modulating Th1\/Th17 and Treg cell responses in NOD mice. Invest Ophthalmol Vis Sci 63(6):12. https:\/\/doi.org\/10.1167\/iovs.63.6.12","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"9023_CR130","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1189\/jlb.0706438","volume":"81","author":"M Thurnher","year":"2007","unstructured":"Thurnher M (2007) Lipids in dendritic cell biology: messengers, effectors, and antigens. J Leukoc Biol 81(1):154\u2013160. https:\/\/doi.org\/10.1189\/jlb.0706438","journal-title":"J Leukoc Biol"},{"issue":"4","key":"9023_CR131","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/ni.2833","volume":"15","author":"B Everts","year":"2014","unstructured":"Everts B et al (2014) TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK\u025b supports the anabolic demands of dendritic cell activation. Nat Immunol 15(4):323\u2013332. https:\/\/doi.org\/10.1038\/ni.2833","journal-title":"Nat Immunol"},{"issue":"1","key":"9023_CR132","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s10020-023-00682-x","volume":"29","author":"K Edwards","year":"2023","unstructured":"Edwards K et al (2023) The role of CD180 in hematological malignancies and inflammatory disorders. Mol Med 29(1):97. https:\/\/doi.org\/10.1186\/s10020-023-00682-x","journal-title":"Mol Med"},{"key":"9023_CR133","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.biochi.2018.07.010","volume":"159","author":"K Kaarniranta","year":"2019","unstructured":"Kaarniranta K et al (2019) Fatty acids and oxidized lipoproteins contribute to autophagy and innate immunity responses upon the degeneration of retinal pigment epithelium and development of age-related macular degeneration. Biochimie 159:49\u201354. https:\/\/doi.org\/10.1016\/j.biochi.2018.07.010","journal-title":"Biochimie"},{"issue":"2","key":"9023_CR134","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12016-020-08791-9","volume":"60","author":"K Koushki","year":"2021","unstructured":"Koushki K et al (2021) Anti-inflammatory action of statins in cardiovascular disease: the role of inflammasome and Toll-like receptor pathways. Clin Rev Allergy Immunol 60(2):175\u2013199. https:\/\/doi.org\/10.1007\/s12016-020-08791-9","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"9023_CR135","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1053\/j.gastro.2012.06.003","volume":"143","author":"J Ibrahim","year":"2012","unstructured":"Ibrahim J et al (2012) Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver. Gastroenterology 143(4):1061\u20131072. https:\/\/doi.org\/10.1053\/j.gastro.2012.06.003","journal-title":"Gastroenterology"},{"key":"9023_CR136","first-page":"242","volume":"61","author":"DF Horrobin","year":"1986","unstructured":"Horrobin DF (1986) Essential fatty acid and prostaglandin metabolism in Sj\u00f6gren\u2019s syndrome, systemic sclerosis and rheumatoid arthritis. Scand J Rheumatol Suppl 61:242\u2013245","journal-title":"Scand J Rheumatol Suppl"},{"issue":"3","key":"9023_CR137","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/jcp.24797","volume":"230","author":"Y Shikama","year":"2015","unstructured":"Shikama Y et al (2015) Palmitate-stimulated monocytes induce adhesion molecule expression in endothelial cells via IL-1 signaling pathway. J Cell Physiol 230(3):732\u2013742. https:\/\/doi.org\/10.1002\/jcp.24797","journal-title":"J Cell Physiol"},{"key":"9023_CR138","doi-asserted-by":"publisher","unstructured":"Mo YQ et al (2022) Lysosomal exocytosis of HSP70 stimulates monocytic BMP6 expression in Sj\u00f6gren\u2019s syndrome. J Clin Invest 132(6). https:\/\/doi.org\/10.1172\/jci152780","DOI":"10.1172\/jci152780"},{"key":"9023_CR139","doi-asserted-by":"publisher","first-page":"983713","DOI":"10.3389\/fendo.2022.983713","volume":"13","author":"MY Chen","year":"2022","unstructured":"Chen MY et al (2022) Profile of crosstalk between glucose and lipid metabolic disturbance and diabetic cardiomyopathy: inflammation and oxidative stress. Front Endocrinol (Lausanne) 13:983713. https:\/\/doi.org\/10.3389\/fendo.2022.983713","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"9023_CR140","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.semarthrit.2010.07.006","volume":"40","author":"EJ ter Borg","year":"2011","unstructured":"ter Borg EJ, Risselada AP, Kelder JC (2011) Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sj\u00f6gren\u2019s syndrome: a retrospective analysis of 65 patients in the Netherlands. Semin Arthritis Rheum 40(6):547\u2013551. https:\/\/doi.org\/10.1016\/j.semarthrit.2010.07.006","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"9023_CR141","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.autrev.2010.05.004","volume":"9","author":"AL Fauchais","year":"2010","unstructured":"Fauchais AL et al (2010) Immunological profile in primary Sj\u00f6gren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev 9(9):595\u2013599. https:\/\/doi.org\/10.1016\/j.autrev.2010.05.004","journal-title":"Autoimmun Rev"},{"issue":"1","key":"9023_CR142","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13018-023-03513-1","volume":"18","author":"R Gao","year":"2023","unstructured":"Gao R et al (2023) Osteoarthritis or arthritis? Toward understanding of primary Sj\u00f6gren\u2019s syndrome patients with arthralgia. J Orthop Surg Res 18(1):41. https:\/\/doi.org\/10.1186\/s13018-023-03513-1","journal-title":"J Orthop Surg Res"},{"issue":"8","key":"9023_CR143","doi-asserted-by":"publisher","first-page":"102867","DOI":"10.1016\/j.autrev.2021.102867","volume":"20","author":"MJ Barrera","year":"2021","unstructured":"Barrera MJ et al (2021) Dysfunctional mitochondria as critical players in the inflammation of autoimmune diseases: potential role in Sj\u00f6gren\u2019s syndrome. Autoimmun Rev 20(8):102867. https:\/\/doi.org\/10.1016\/j.autrev.2021.102867","journal-title":"Autoimmun Rev"},{"key":"9023_CR144","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jpba.2019.06.005","volume":"174","author":"HB Ferreira","year":"2019","unstructured":"Ferreira HB et al (2019) Lipidomics in autoimmune diseases with main focus on systemic lupus erythematosus. J Pharm Biomed Anal 174:386\u2013395. https:\/\/doi.org\/10.1016\/j.jpba.2019.06.005","journal-title":"J Pharm Biomed Anal"},{"key":"9023_CR145","doi-asserted-by":"publisher","first-page":"845209","DOI":"10.3389\/fimmu.2022.845209","volume":"13","author":"N Li","year":"2022","unstructured":"Li N et al (2022) A link between mitochondrial dysfunction and the immune microenvironment of salivary glands in primary Sjogren\u2019s syndrome. Front Immunol 13:845209. https:\/\/doi.org\/10.3389\/fimmu.2022.845209","journal-title":"Front Immunol"},{"issue":"4","key":"9023_CR146","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cmet.2019.02.011","volume":"29","author":"IY Benador","year":"2019","unstructured":"Benador IY et al (2019) Mitochondria bound to lipid droplets: where mitochondrial dynamics regulate lipid storage and utilization. Cell Metab 29(4):827\u2013835. https:\/\/doi.org\/10.1016\/j.cmet.2019.02.011","journal-title":"Cell Metab"},{"key":"9023_CR147","doi-asserted-by":"publisher","unstructured":"Nowinski SM et al (2020) Mitochondrial fatty acid synthesis coordinates oxidative metabolism in mammalian mitochondria. eLife 9. https:\/\/doi.org\/10.7554\/eLife.58041","DOI":"10.7554\/eLife.58041"},{"key":"9023_CR148","doi-asserted-by":"publisher","first-page":"103014","DOI":"10.1016\/j.jaut.2023.103014","volume":"136","author":"S Katsiougiannis","year":"2023","unstructured":"Katsiougiannis S et al (2023) Salivary gland epithelial cell in Sj\u00f6gren\u2019s syndrome: metabolic shift and altered mitochondrial morphology toward an innate immune cell function. J Autoimmun 136:103014. https:\/\/doi.org\/10.1016\/j.jaut.2023.103014","journal-title":"J Autoimmun"},{"issue":"9","key":"9023_CR149","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/ard.48.9.765","volume":"48","author":"CA Swanson","year":"1989","unstructured":"Swanson CA, Levy JA, Morrow WJ (1989) Effect of low dietary lipid on the development of Sj\u00f6gren\u2019s syndrome and haematological abnormalities in (NZB x NZW)F1 mice. Ann Rheum Dis 48(9):765\u2013770. https:\/\/doi.org\/10.1136\/ard.48.9.765","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"9023_CR150","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1023\/a:1006620130114","volume":"20","author":"AR Muthukumar","year":"2000","unstructured":"Muthukumar AR et al (2000) Calorie restriction decreases proinflammatory cytokines and polymeric Ig receptor expression in the submandibular glands of autoimmune prone (NZB x NZW)F1 mice. J Clin Immunol 20(5):354\u2013361. https:\/\/doi.org\/10.1023\/a:1006620130114","journal-title":"J Clin Immunol"},{"issue":"4","key":"9023_CR151","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/s0952-3278(98)90136-3","volume":"59","author":"P Oxholm","year":"1998","unstructured":"Oxholm P et al (1998) Essential fatty acid status in cell membranes and plasma of patients with primary Sjogren\u2019s syndrome. Correlations to clinical and immunologic variables using a new model for classification and assessment of disease manifestations. Prostaglandins Leukot Essent Fatty Acids 59(4):239\u201345. https:\/\/doi.org\/10.1016\/s0952-3278(98)90136-3","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"4","key":"9023_CR152","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/ajcn\/82.4.887","volume":"82","author":"B Miljanovi\u0107","year":"2005","unstructured":"Miljanovi\u0107 B et al (2005) Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clin Nutr 82(4):887\u2013893. https:\/\/doi.org\/10.1093\/ajcn\/82.4.887","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"9023_CR153","first-page":"34","volume":"38 Suppl 126","author":"CY Castrej\u00f3n-Morales","year":"2020","unstructured":"Castrej\u00f3n-Morales CY et al (2020) Omega-3 and omega-6 fatty acids in primary Sj\u00f6gren\u2019s syndrome: clinical meaning and association with inflammation. Clin Exp Rheumatol 38 Suppl 126(4):34\u201339","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"9023_CR154","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s00417-009-1080-z","volume":"247","author":"S Viau","year":"2009","unstructured":"Viau S et al (2009) Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Graefes Arch Clin Exp Ophthalmol 247(8):1039\u20131050. https:\/\/doi.org\/10.1007\/s00417-009-1080-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"9023_CR155","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1080\/03009740252937577","volume":"31","author":"E Theander","year":"2002","unstructured":"Theander E et al (2002) Gammalinolenic acid treatment of fatigue associated with primary Sj\u00f6gren\u2019s syndrome. Scand J Rheumatol 31(2):72\u201379. https:\/\/doi.org\/10.1080\/03009740252937577","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"9023_CR156","doi-asserted-by":"publisher","first-page":"Itc81","DOI":"10.7326\/aitc202306200","volume":"176","author":"M Arvanitis","year":"2023","unstructured":"Arvanitis M, Lowenstein CJ (2023) Dyslipidemia. Ann Intern Med 176(6):Itc81-itc96. https:\/\/doi.org\/10.7326\/aitc202306200","journal-title":"Ann Intern Med"},{"issue":"5","key":"9023_CR157","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10787-012-0132-x","volume":"20","author":"S Reina","year":"2012","unstructured":"Reina S et al (2012) Atorvastatin inhibits the inflammatory response caused by anti-M(3) peptide IgG in patients with primary Sj\u00f6gren\u2019s syndrome. Inflammopharmacology 20(5):267\u2013275. https:\/\/doi.org\/10.1007\/s10787-012-0132-x","journal-title":"Inflammopharmacology"},{"issue":"7","key":"9023_CR158","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00108-023-01536-8","volume":"64","author":"KG Parhofer","year":"2023","unstructured":"Parhofer KG (2023) Update lipidology: evidence-based treatment of dyslipidemia. Inn Med (Heidelb) 64(7):611\u2013621. https:\/\/doi.org\/10.1007\/s00108-023-01536-8","journal-title":"Inn Med (Heidelb)"},{"issue":"3","key":"9023_CR159","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3290\/j.ohpd.a30172","volume":"11","author":"G Mumcu","year":"2013","unstructured":"Mumcu G et al (2013) Salivary and serum B-cell activating factor (BAFF) levels after hydroxychloroquine treatment in primary Sj\u00f6gren\u2019s syndrome. Oral Health Prev Dent 11(3):229\u2013234. https:\/\/doi.org\/10.3290\/j.ohpd.a30172","journal-title":"Oral Health Prev Dent"},{"issue":"4","key":"9023_CR160","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1136\/ard.58.4.253","volume":"58","author":"M Tishler","year":"1999","unstructured":"Tishler M et al (1999) Hydroxychloroquine treatment for primary Sj\u00f6gren\u2019s syndrome: its effect on salivary and serum inflammatory markers. Ann Rheum Dis 58(4):253\u2013256. https:\/\/doi.org\/10.1136\/ard.58.4.253","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"9023_CR161","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3899\/jrheum.131156","volume":"41","author":"MP Migkos","year":"2014","unstructured":"Migkos MP et al (2014) Effect of hydroxychloroquine on the lipid profile of patients with Sj\u00f6gren syndrome. J Rheumatol 41(5):902\u2013908. https:\/\/doi.org\/10.3899\/jrheum.131156","journal-title":"J Rheumatol"},{"issue":"6","key":"9023_CR162","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/jac\/dkv018","volume":"70","author":"MA Al-Bari","year":"2015","unstructured":"Al-Bari MA (2015) Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J Antimicrob Chemother 70(6):1608\u20131621. https:\/\/doi.org\/10.1093\/jac\/dkv018","journal-title":"J Antimicrob Chemother"},{"issue":"6 Pt 2","key":"9023_CR163","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1016\/j.lpm.2014.03.007","volume":"43","author":"N Costedoat-Chalumeau","year":"2014","unstructured":"Costedoat-Chalumeau N et al (2014) Hydroxychloroquine: a multifaceted treatment in lupus. Presse Med 43(6 Pt 2):e167\u2013e180. https:\/\/doi.org\/10.1016\/j.lpm.2014.03.007","journal-title":"Presse Med"},{"key":"9023_CR164","doi-asserted-by":"publisher","first-page":"1191692","DOI":"10.3389\/fphar.2023.1191692","volume":"14","author":"J Yin","year":"2023","unstructured":"Yin J et al (2023) HECT, UBA and WWE domain containing 1 represses cholesterol efflux during CD4(+) T cell activation in Sj\u00f6gren\u2019s syndrome. Front Pharmacol 14:1191692. https:\/\/doi.org\/10.3389\/fphar.2023.1191692","journal-title":"Front Pharmacol"},{"issue":"5","key":"9023_CR165","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s10238-022-00939-5","volume":"23","author":"J Yin","year":"2023","unstructured":"Yin J et al (2023) CYP51-mediated cholesterol biosynthesis is required for the proliferation of CD4+ T cells in Sjogren\u2019s syndrome. Clin Exp Med 23(5):1691\u20131711. https:\/\/doi.org\/10.1007\/s10238-022-00939-5","journal-title":"Clin Exp Med"},{"issue":"1","key":"9023_CR166","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/nu15010229","volume":"15","author":"I Alexandropoulou","year":"2023","unstructured":"Alexandropoulou I et al (2023) Ceramides in autoimmune rheumatic diseases: existing evidence and therapeutic considerations for diet as an anticeramide treatment. Nutrients 15(1):229. https:\/\/doi.org\/10.3390\/nu15010229","journal-title":"Nutrients"},{"issue":"1","key":"9023_CR167","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/00220345221119710","volume":"102","author":"J Li","year":"2023","unstructured":"Li J et al (2023) Anticeramide improves Sj\u00f6gren\u2019s syndrome by blocking BMP6-induced Th1. J Dent Res 102(1):93\u2013102. https:\/\/doi.org\/10.1177\/00220345221119710","journal-title":"J Dent Res"},{"key":"9023_CR168","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-pathol-050420-025929","volume":"17","author":"K Kano","year":"2022","unstructured":"Kano K, Aoki J, Hla T (2022) Lysophospholipid mediators in health and disease. Annu Rev Pathol 17:459\u2013483. https:\/\/doi.org\/10.1146\/annurev-pathol-050420-025929","journal-title":"Annu Rev Pathol"},{"issue":"16","key":"9023_CR169","doi-asserted-by":"publisher","first-page":"27240","DOI":"10.18632\/oncotarget.15916","volume":"8","author":"E Park","year":"2017","unstructured":"Park E et al (2017) Inhibition of lysophosphatidic acid receptor ameliorates Sj\u00f6gren\u2019s syndrome in NOD mice. Oncotarget 8(16):27240\u201327251. https:\/\/doi.org\/10.18632\/oncotarget.15916","journal-title":"Oncotarget"},{"issue":"3","key":"9023_CR170","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.4049\/jimmunol.180.3.1921","volume":"180","author":"M Sekiguchi","year":"2008","unstructured":"Sekiguchi M et al (2008) Role of sphingosine 1-phosphate in the pathogenesis of Sj\u00f6gren\u2019s syndrome. J Immunol 180(3):1921\u20131928. https:\/\/doi.org\/10.4049\/jimmunol.180.3.1921","journal-title":"J Immunol"},{"issue":"38","key":"9023_CR171","doi-asserted-by":"publisher","first-page":"63417","DOI":"10.18632\/oncotarget.18823","volume":"8","author":"T Xu","year":"2017","unstructured":"Xu T et al (2017) Leptin\/OB-R pathway promotes IL-4 secretion from B lymphocytes and induces salivary gland epithelial cell apoptosis in Sj\u00f6gren\u2019s syndrome. Oncotarget 8(38):63417\u201363429. https:\/\/doi.org\/10.18632\/oncotarget.18823","journal-title":"Oncotarget"},{"issue":"4","key":"9023_CR172","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.bbrc.2016.11.121","volume":"482","author":"T Xu","year":"2017","unstructured":"Xu T et al (2017) Leptin\/OB-R signaling is elevated in mice with Sj\u00f6gren\u2019s syndrome and is implicated in disease pathogenesis. Biochem Biophys Res Commun 482(4):835\u2013842. https:\/\/doi.org\/10.1016\/j.bbrc.2016.11.121","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"9023_CR173","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.3390\/ijms22115446","volume":"22","author":"P Raman","year":"2021","unstructured":"Raman P, Khanal S (2021) Leptin in atherosclerosis: focus on macrophages, endothelial and smooth muscle cells. Int J Mol Sci 22(11):5446. https:\/\/doi.org\/10.3390\/ijms22115446","journal-title":"Int J Mol Sci"},{"key":"9023_CR174","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cyto.2018.08.002","volume":"111","author":"D Chougule","year":"2018","unstructured":"Chougule D et al (2018) Adipokine interactions promote the pathogenesis of systemic lupus erythematosus. Cytokine 111:20\u201327. https:\/\/doi.org\/10.1016\/j.cyto.2018.08.002","journal-title":"Cytokine"},{"issue":"2","key":"9023_CR175","doi-asserted-by":"publisher","first-page":"e148552","DOI":"10.1172\/jci148552","volume":"132","author":"G Robinson","year":"2022","unstructured":"Robinson G et al (2022) Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies. J Clin Invest 132(2):e148552. https:\/\/doi.org\/10.1172\/jci148552","journal-title":"J Clin Invest"},{"issue":"6","key":"9023_CR176","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1089\/108076803322660495","volume":"19","author":"C Beauregard","year":"2003","unstructured":"Beauregard C, Brandt PC (2003) Peroxisome proliferator-activated receptor agonists inhibit interleukin-1beta-mediated nitric oxide production in cultured lacrimal gland acinar cells. J Ocul Pharmacol Ther 19(6):579\u2013587. https:\/\/doi.org\/10.1089\/108076803322660495","journal-title":"J Ocul Pharmacol Ther"},{"issue":"8","key":"9023_CR177","first-page":"4886","volume":"7","author":"X Li","year":"2014","unstructured":"Li X et al (2014) Anti-inflammatory effect of peroxisome proliferator-activated receptor-\u03b3 (PPAR-\u03b3) on non-obese diabetic mice with Sjogren\u2019s syndrome. Int J Clin Exp Pathol 7(8):4886\u20134894","journal-title":"Int J Clin Exp Pathol"},{"key":"9023_CR178","doi-asserted-by":"publisher","first-page":"102335","DOI":"10.1016\/j.jaut.2019.102335","volume":"104","author":"S Katsiougiannis","year":"2019","unstructured":"Katsiougiannis S, Tenta R, Skopouli FN (2019) Autoimmune epithelitis (Sj\u00f6gren\u2019s syndrome); the impact of metabolic status of glandular epithelial cells on auto-immunogenicity. J Autoimmun 104:102335. https:\/\/doi.org\/10.1016\/j.jaut.2019.102335","journal-title":"J Autoimmun"},{"key":"9023_CR179","doi-asserted-by":"publisher","first-page":"102723","DOI":"10.1016\/j.jaut.2021.102723","volume":"124","author":"JFJ Bogie","year":"2021","unstructured":"Bogie JFJ et al (2021) Liver X receptor beta deficiency attenuates autoimmune-associated neuroinflammation in a T cell-dependent manner. J Autoimmun 124:102723. https:\/\/doi.org\/10.1016\/j.jaut.2021.102723","journal-title":"J Autoimmun"},{"issue":"19","key":"9023_CR180","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1002\/1873-3468.12702","volume":"591","author":"IG Schulman","year":"2017","unstructured":"Schulman IG (2017) Liver X receptors link lipid metabolism and inflammation. FEBS Lett 591(19):2978\u20132991. https:\/\/doi.org\/10.1002\/1873-3468.12702","journal-title":"FEBS Lett"},{"issue":"7","key":"9023_CR181","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3760\/cma.j.cn121430-20200224-00196","volume":"32","author":"J Wang","year":"2020","unstructured":"Wang J, Xia H, Yao S (2020) Research progress on the mechanism of pro-inflammatory regression mediators promoting inflammation regression by regulating immune cells. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 32(7):873\u2013876. https:\/\/doi.org\/10.3760\/cma.j.cn121430-20200224-00196","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"8","key":"9023_CR182","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.20020760","volume":"196","author":"CN Serhan","year":"2002","unstructured":"Serhan CN et al (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196(8):1025\u20131037. https:\/\/doi.org\/10.1084\/jem.20020760","journal-title":"J Exp Med"},{"issue":"7","key":"9023_CR183","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.4049\/jimmunol.1000833","volume":"186","author":"DA Dartt","year":"2011","unstructured":"Dartt DA et al (2011) Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. J Immunol 186(7):4455\u20134466. https:\/\/doi.org\/10.4049\/jimmunol.1000833","journal-title":"J Immunol"},{"issue":"9","key":"9023_CR184","doi-asserted-by":"publisher","first-page":"C1331","DOI":"10.1152\/ajpcell.00207.2011","volume":"302","author":"O Odusanwo","year":"2012","unstructured":"Odusanwo O et al (2012) Resolvin D1 prevents TNF-\u03b1-mediated disruption of salivary epithelial formation. Am J Physiol Cell Physiol 302(9):C1331\u2013C1345. https:\/\/doi.org\/10.1152\/ajpcell.00207.2011","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"9023_CR185","doi-asserted-by":"publisher","first-page":"C178","DOI":"10.1152\/ajpcell.00284.2013","volume":"306","author":"JW Nelson","year":"2014","unstructured":"Nelson JW et al (2014) ALX\/FPR2 receptor for RvD1 is expressed and functional in salivary glands. Am J Physiol Cell Physiol 306(2):C178\u2013C185. https:\/\/doi.org\/10.1152\/ajpcell.00284.2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"9023_CR186","doi-asserted-by":"publisher","first-page":"45525","DOI":"10.1038\/srep45525","volume":"7","author":"CS Wang","year":"2017","unstructured":"Wang CS et al (2017) AT-RvD1 promotes resolution of inflammation in NOD\/ShiLtJ mice. Sci Rep 7:45525. https:\/\/doi.org\/10.1038\/srep45525","journal-title":"Sci Rep"},{"issue":"7","key":"9023_CR187","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/rheumatology\/kez072","volume":"58","author":"S Dean","year":"2019","unstructured":"Dean S et al (2019) Aspirin triggered resolvin D1 reduces inflammation and restores saliva secretion in a Sj\u00f6gren\u2019s syndrome mouse model. Rheumatology (Oxford) 58(7):1285\u20131292. https:\/\/doi.org\/10.1093\/rheumatology\/kez072","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"9023_CR188","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/cts.12930","volume":"14","author":"VK Yellepeddi","year":"2021","unstructured":"Yellepeddi VK et al (2021) Predicting resolvin D1 pharmacokinetics in humans with physiologically-based pharmacokinetic modeling. Clin Transl Sci 14(2):683\u2013691. https:\/\/doi.org\/10.1111\/cts.12930","journal-title":"Clin Transl Sci"},{"issue":"2","key":"9023_CR189","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/cre2.260","volume":"6","author":"VK Yellepeddi","year":"2020","unstructured":"Yellepeddi VK, Baker OJ (2020) Predictive modeling of aspirin-triggered resolvin D1 pharmacokinetics for the study of Sj\u00f6gren\u2019s syndrome. Clin Exp Dent Res 6(2):225\u2013235. https:\/\/doi.org\/10.1002\/cre2.260","journal-title":"Clin Exp Dent Res"},{"issue":"3","key":"9023_CR190","doi-asserted-by":"publisher","first-page":"543","DOI":"10.14218\/jcth.2021.00271","volume":"10","author":"LD Averbukh","year":"2022","unstructured":"Averbukh LD et al (2022) Statin-induced liver injury patterns: a clinical review. J Clin Transl Hepatol 10(3):543\u2013552. https:\/\/doi.org\/10.14218\/jcth.2021.00271","journal-title":"J Clin Transl Hepatol"},{"key":"9023_CR191","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2147\/ijgm.s460305","volume":"17","author":"MM Ma","year":"2024","unstructured":"Ma MM et al (2024) Statin-associated liver dysfunction and muscle injury: epidemiology, mechanisms, and management strategies. Int J Gen Med 17:2055\u20132063. https:\/\/doi.org\/10.2147\/ijgm.s460305","journal-title":"Int J Gen Med"},{"key":"9023_CR192","doi-asserted-by":"publisher","unstructured":"Skoczy\u0144ska A et al (2024) PPARs in clinical experimental medicine after 35 years of worldwide scientific investigations and medical experiments. Biomolecules 14n7. https:\/\/doi.org\/10.3390\/biom14070786","DOI":"10.3390\/biom14070786"},{"key":"9023_CR193","doi-asserted-by":"publisher","first-page":"584303","DOI":"10.3389\/fimmu.2020.584303","volume":"11","author":"MT Bilotta","year":"2020","unstructured":"Bilotta MT et al (2020) Liver X receptors: regulators of cholesterol metabolism, inflammation, autoimmunity, and cancer. Front Immunol 11:584303. https:\/\/doi.org\/10.3389\/fimmu.2020.584303","journal-title":"Front Immunol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09023-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-025-09023-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09023-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T19:09:40Z","timestamp":1739300980000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-025-09023-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":193,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9023"],"URL":"https:\/\/doi.org\/10.1007\/s12016-025-09023-8","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"7 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15"}}